Bonneux L
Federaal Kenniscentrum voor de Gezondheidszorg (KCE), Residence Palace Ioe verdieping, Wetstraat 155, B-1040 Brussel, België.
Ned Tijdschr Geneeskd. 2005 Jul 16;149(29):1619.
In the treatment of confirmed influenza, neuraminidase inhibitors yield only a limited reduction in the duration of disease and are neither efficacious nor cost-effective. Neuraminidase inhibitors would be cost-effective if a deadly influenza virus that is highly sensitive to oseltamivir causes a pandemic soon. If not, then the money invested in establishing a store of oseltamivir is wasted and lost to the health-care sector.
在确诊流感的治疗中,神经氨酸酶抑制剂仅能有限缩短病程,且既无疗效也不具有成本效益。如果对奥司他韦高度敏感的致命流感病毒很快引发大流行,那么神经氨酸酶抑制剂将具有成本效益。否则,投入建立奥司他韦储备库的资金就会被浪费,无法用于医疗保健领域。